Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium hypochlorite + ethanol is a combination of two chemical agents commonly used for disinfection and antisepsis. Sodium hypochlorite acts as a strong oxidizing agent, disrupting microbial cell walls and inactivating bacteria, viruses, and fungi through oxidation reactions[1][6]. Ethanol is an alcohol that denatures proteins and dissolves lipid membranes, providing rapid antimicrobial action. When combined (often referred to as "alcoholic bleach"), the mixture can exhibit enhanced biocidal activity compared to either agent alone, reducing required contact time for effective disinfection[10]. However, this combination is not typically formulated or marketed as a pharmaceutical drug but may be used in laboratory or industrial settings for surface disinfection. The mechanism of action involves both oxidative damage (from sodium hypochlorite) and protein/lipid denaturation (from ethanol). Caution must be exercised when mixing these chemicals due to potential chemical reactivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium hypochlorite + ethanol.